Dyne Therapeutics, Inc. (DYN)
Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.
Address
1560 TRAPELO ROAD
WALTHAM, MA 02451
Founded
2017
Number of Employees
141
Website
http://www.dyne-tx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)